Barbara Kazmierczak, MD, PhD
Gustavus and Louise Pfeiffer Research Foundation M.D.-Ph.D. Program Director and Professor of Medicine (Infectious Diseases) and of Microbial PathogenesisCards
Additional Titles
Professor, Microbial Pathogenesis
Director, MD-PhD Program, Yale University
Publications Overview
- 64 Publications
- 4,400 Citations
- 20 Yale Co-Authors
MD-PhD Program
Additional Titles
Professor, Microbial Pathogenesis
Director, MD-PhD Program, Yale University
Publications Overview
- 64 Publications
- 4,400 Citations
- 20 Yale Co-Authors
MD-PhD Program
Additional Titles
Professor, Microbial Pathogenesis
Director, MD-PhD Program, Yale University
Publications Overview
- 64 Publications
- 4,400 Citations
- 20 Yale Co-Authors
MD-PhD Program
About
Titles
Gustavus and Louise Pfeiffer Research Foundation M.D.-Ph.D. Program Director and Professor of Medicine (Infectious Diseases) and of Microbial Pathogenesis
Professor, Microbial Pathogenesis; Director, MD-PhD Program, Yale University
Biography
Dr. Kazmierczak received her PhD from Rockefeller University (1993) and her MD from Cornell University Medical College (1994), both in New York City. She completed an Internal Medicine residency and Infectious Diseases fellowship training at the University of California, San Francisco, and joined the Yale faculty in 2001. She is currently a Professor of Medicine and Microbial Pathogenesis, and Director of the MD-PhD program at Yale.
Dr. Kazmierczak's research program is broadly focused on bacterial and host factors that allow opportunistic infections to occur. Using Pseudomonas aeruginosa as a clinically relevant model, her lab addresses fundamental questions of how cell-envelope spanning bacterial machines - the Type 3 secretion system, Type 4 pili and polar flagellum - are assembled, regulated, and used during infection. She has also identified host responses directed at components of these virulence associated structures, in particular those mediated by the NLRC4 inflammasome. Inflammatory responses to bacteria are also a focus of her work on microbiome-host interactions in infants with Cystic Fibrosis, where her lab has used longitudinal data acquired over five years from cohorts of patients and controls to understand gut microbiome composition and the inflammatory and metabolic responses at this site.
Dr. Kazmierczak has been recognized as a Burroughs-Wellcome Fund Investigator in the Pathogenesis of Infectious Diseases (2007), a Donaghue Investigator (2002), and a Hellman Family Fellow (2002). She is a Fellow of the Infectious Diseases Society of America and an elected member of the American Society for Clinical Investigation and the American Academy for Microbiology.
Appointments
Infectious Diseases
ProfessorPrimaryMicrobial Pathogenesis
ProfessorSecondary
Other Departments & Organizations
- BioMed Amgen Scholars Program
- CPIRT - Center for Pulmonary Injury, Inflammation, Repair and Therapeutics
- Discovery to Cure Internship
- Infectious Diseases
- Internal Medicine
- MD-PhD Program
- Microbial Pathogenesis
- Microbiology
- Molecular Medicine, Pharmacology, and Physiology
- Yale Combined Program in the Biological and Biomedical Sciences (BBS)
- Yale Medicine
- Yale Ventures
Education & Training
- Assistant Adjunct Professor
- University of California, San Francisco (2001)
- Fellow
- University of California, San Francisco (1999)
- Resident
- University of California, San Francisco (1996)
- Intern
- University of California, San Francisco (1995)
- MD
- Cornell University Medical College (1994)
- PhD
- Rockefeller University (1993)
- BA
- University of Chicago (1986)
- MS
- University of Chicago (1986)
Research
Overview
Dr. Kazmierczak studies opportunistic pathogens, with a primary emphasis on Pseudomonas aeruginosa. Her group is focused on understanding how microorganisms transition between commensal relationships with humans to causing disease. The following research projects are active in the laboratory.
- Regulation of genes involved in biofilm formation, Type 3 secretion and Type 6 secretion in Pseudomonas aeruginosa.
- Regulatory networks that control and coordinate pilus and flagellar assembly in response to environmental cues in Pseudomonas aeruginosa.
- Modulation of mammalian innate immune responses to Pseudomonas aeruginosa infection by the bacterial Type 3 secretion system apparatus and effectors.
- Single-cell analysis of Type 3 secretion system expression: how is phenotypic heterogeneity generated within a clonal population, and how does it affect fitness of a pathogen in the host?
- Novel approaches to understanding intrinsic antibiotic resistance and developing new antimicrobials.
- Acquisition of gut and airway microbiome populations in infants with Cystic Fibrosis and healthy controls: consequences for disease progression and development of inflammation.
Medical Research Interests
ORCID
0000-0002-8162-803X- View Lab Website
MD-PhD Program
Research at a Glance
Yale Co-Authors
Publications Timeline
Research Interests
Thomas Murray, MD, PhD
Jeanne Hendrickson, MD
Marie Egan, MD
Anita Huttner, MD
Christopher Tormey, MD
David Peaper, MD, PhD
Immunity, Innate
Host-Pathogen Interactions
Biomedical Research
Pseudomonas
Education, Medical, Graduate
Publications
2024
Bacterial cell surface characterization by phage display coupled to high-throughput sequencing
Grun C, Jain R, Schniederberend M, Shoemaker C, Nelson B, Kazmierczak B. Bacterial cell surface characterization by phage display coupled to high-throughput sequencing. Nature Communications 2024, 15: 7502. PMID: 39209859, PMCID: PMC11362561, DOI: 10.1038/s41467-024-51912-7.Peer-Reviewed Original ResearchMeSH Keywords and ConceptsConceptsBacterial cell surfaceCell surfacePhage displayP. aeruginosa virulence factorsHigh-throughput DNA sequencingHigh-throughput sequencingPhage display panningCapacity of bacteriaCamelid single-domain antibodiesVirulence factorsDNA sequencesBacterial genotypesPhageSingle-domain antibodiesPseudomonas aeruginosaHost defenseBiological informationAntimicrobial resistanceLiving cellsSequenceChronic infectionCell surface characterizationAdaptive changesCellsBacteriaIs it time to reduce the length of postgraduate training for physician-scientists in internal medicine?
Gallagher E, Conlin P, Kazmierczak B, Vyas J, Ajijola O, Kontos C, Baiocchi R, Rhee K, Hu P, Isales C, Williams C, Rockey D. Is it time to reduce the length of postgraduate training for physician-scientists in internal medicine? JCI Insight 2024, 9: e178214. PMID: 38775155, PMCID: PMC11141926, DOI: 10.1172/jci.insight.178214.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsMedical school graduatesCareer development awardsInternal medicine residency graduatesResidency graduatesRetention of physician-scientistsInternal medicinePostgraduate trainingPhysician-scientistsSchool graduatesK awardsK awardeesMD-PhD graduatesPatient careComplete trainingTraining durationMedian timeMedical knowledgeDevelopment AwardNIH RePORTERTrainingIK2GraduatesAwardeesMedicineCareInterventions to support fellowship application success among predoctoral physician-scientists
Fitzsimonds R, Gorelick F, Kazmierczak B. Interventions to support fellowship application success among predoctoral physician-scientists. JCI Insight 2024, 9: e175857. PMID: 38456505, PMCID: PMC10972582, DOI: 10.1172/jci.insight.175857.Peer-Reviewed Original ResearchCitationsAltmetric
2023
Structural insights into the career path between pre- and postgraduate physician-scientist training programs
Williams C, Gallagher E, Rockey D, Ajijola O, Hu P, Kazmierczak B, Kontos C, Vyas J, Zaidi M, Rhee K. Structural insights into the career path between pre- and postgraduate physician-scientist training programs. ELife 2023, 12: e87148. PMID: 37782020, PMCID: PMC10545427, DOI: 10.7554/elife.87148.Peer-Reviewed Original ResearchCitationsAltmetricSingle Sequential Bacteriophage Therapy Decreases Pseudomonas Virulence More Than a Cocktail Approach
Stanley G, Chan B, Wuerstle S, Grun C, Kazmierczak B, Sun Y, Kortright K, Turner P, Koff J. Single Sequential Bacteriophage Therapy Decreases Pseudomonas Virulence More Than a Cocktail Approach. 2023, a1228-a1228. DOI: 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a1228.Peer-Reviewed Original ResearchCitationsIdentification of Efflux Substrates Using a Riboswitch-Based Reporter in Pseudomonas aeruginosa
Urdaneta-Páez V, Hamchand R, Anthony K, Crawford J, Sutherland A, Kazmierczak B. Identification of Efflux Substrates Using a Riboswitch-Based Reporter in Pseudomonas aeruginosa. MSphere 2023, 8: e00069-23. PMID: 36946743, PMCID: PMC10117056, DOI: 10.1128/msphere.00069-23.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsLiquid chromatography-mass spectrometryCompound uptakeHigh-resolution liquid chromatography-mass spectrometryChromatography-mass spectrometryNovel antibioticsHigh-throughput screeningRational designMore rational designChemical librariesDiverse compoundsInitial hitsSelect compoundsPermeable compoundsDrug candidatesCompoundsStructural propertiesBacterial cellsPowerful methodAntifolate drugsSubstrateSpectrometrySynthesisPseudomonas aeruginosaClasses of antibioticsMembrane
2022
Assessment of polymicrobial interactions in bacterial isolates from transfused platelet units associated with sepsis
Kerantzas CA, Merwede J, Snyder EL, Hendrickson JE, Tormey CA, Kazmierczak BI, Peaper DR. Assessment of polymicrobial interactions in bacterial isolates from transfused platelet units associated with sepsis. Transfusion 2022, 62: 2458-2463. PMID: 36178430, PMCID: PMC11472026, DOI: 10.1111/trf.17136.Peer-Reviewed Original ResearchCitationsMeSH Keywords and ConceptsConceptsAcinetobacter calcoaceticus-baumannii complexBlood productsS. saprophyticusPlatelet unitsContaminated blood productsCDC investigationsApheresis platelet productsTransfusion reactionsPolymicrobial contaminationPlatelet productsDisease controlBacterial isolatesStudy designStaphylococcus saprophyticusPolymicrobial interactionsCDC casesSaprophyticusFuture studiesPotential interactionsCommon sourceSepsisIsolatesCasesCoaggregationPearls of wisdom for aspiring physician-scientist residency applicants and program directors
Gallagher EJ, Rockey DC, Kontos CD, Vyas JM, Brass LF, Hu PJ, Isales CM, Ajijola OA, Rathmell WK, Conlin PR, Baiocchi RA, Kazmierczak BI, Akabas MH, Williams CS. Pearls of wisdom for aspiring physician-scientist residency applicants and program directors. JCI Insight 2022, 7: e158467. PMID: 35315364, PMCID: PMC8986063, DOI: 10.1172/jci.insight.158467.Peer-Reviewed Original ResearchCitationsAltmetric
2021
A Primed Subpopulation of Bacteria Enables Rapid Expression of the Type 3 Secretion System in Pseudomonas aeruginosa
Lin CK, Lee DSW, McKeithen-Mead S, Emonet T, Kazmierczak B. A Primed Subpopulation of Bacteria Enables Rapid Expression of the Type 3 Secretion System in Pseudomonas aeruginosa. MBio 2021, 12: 10.1128/mbio.00831-21. PMID: 34154400, PMCID: PMC8262847, DOI: 10.1128/mbio.00831-21.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsType 3 secretion systemSecretion systemT3SS expressionVirulence traitsSpecific virulence traitsHuman disease severityComplex nanomachinesT3SS genesP. aeruginosa cellsReproductive fitnessIsogenic cellsHeterogeneous expressionCell envelopeT3SS effectorsMotility organellesReservoir of cellsCritical virulence traitsGene expressionRegulatory mechanismsSubpopulation of cellsGram-negative pathogensFluorescent reportersDivision timeP. aeruginosaPseudomonas aeruginosa
2020
Co-Culture of Acinetobacter calcoaceticus-baumannii complex and Staphylococcus saprophyticus Supports Simple Point Contamination Model in Recent Cases of Transfusion-Related Sepsis
Kerantzas C, Merwede J, Snyder E, Hendrickson J, Tormey C, Kazmierczak B, Peaper D. Co-Culture of Acinetobacter calcoaceticus-baumannii complex and Staphylococcus saprophyticus Supports Simple Point Contamination Model in Recent Cases of Transfusion-Related Sepsis. American Journal Of Clinical Pathology 2020, 154: s14-s14. DOI: 10.1093/ajcp/aqaa137.025.Peer-Reviewed Original Research
Academic Achievements & Community Involvement
activity Yale University
CommitteesMemberDetailsMD/PhD Faculty Committee09/01/2004 - Presentactivity MD-PhD Steering Committee, GREAT Group, AAMC
Professional OrganizationsMemberDetails06/30/2017 - Presenthonor Elected Member, AAM
National AwardAmerican Academy for MicrobiologyDetails01/29/2019United Stateshonor Distinguished Lecturer
National AwardAmerican Society for MicrobiologyDetails07/01/2018United Statesactivity Yale University
CommitteesMemberDetailsAssociate Director for Basic Research, MD-PhD Program07/01/2010 - 08/30/2014
Clinical Care
Overview
Clinical Specialties
Board Certifications
Infectious Disease
- Certification Organization
- AB of Internal Medicine
- Latest Certification Date
- 2019
- Original Certification Date
- 1999
Are You a Patient?
View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.
View Doctor ProfileNews & Links
Media
- A Type 3 secretion system transcriptional reporter driving sfGFP expression reveals variation among genetically identical bacteria exposed to conditions that induce this virulence system.
News
- June 05, 2024
Welcome to the 2024 Yale BioMed Amgen, ACS, BP-Endure, and Summer Undergraduate Research Scholars
- July 05, 2023
Get In the Know! Infectious Diseases Fellowships
- July 21, 2022
Dr. Barbara Kazmierczak Is New Vice Chair, Basic Research
- June 27, 2022
Shung, Goldman-Israelow Present 2022 Dostanic Lectures
Get In Touch
Contacts
Locations
The Anlyan Center
Academic Office
300 Cedar Street, Ste S169A
New Haven, CT 06519
The Anlyan Center
Lab
300 Cedar Street, Ste S140
New Haven, CT 06519
Patient Care Locations
Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.
Events
School Only CancelledSpeakers to be announced.
School Only Speakers to be announced.
School Only Speakers to be announced.
School Only Speakers to be announced.